• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 17 (2), 2021
  3. 65-72
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2021 | Volume: 17 | Issue: 2 | Page No.: 65-72
DOI: 10.3923/ijp.2021.65.72

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 389

Authors


Sefa Ince

Country: Turkey

Mehmet Ozer

Country: Turkey

Berrin Goktug Kadioglu

Country: Turkey

Mehmet Kuzucu

Country: Turkey

Betul Gundogdu

Country: Turkey

Cebrail Gursul

Country: Turkey

Zeynep Suleyman

Country: Turkey

Halis  Suleyman

Halis Suleyman

LiveDNA: 90.23571

Keywords


  • cytokine
  • histopathologic injuries
  • ischemia
  • malondialdehyde
  • reperfusion
  • SOIR group
  • Sunitinib
Research Article

Biochemical and Histopathological Evaluation of Sunitinib Effect on Ovarian Injuries by Ischemia-Reperfusion in Rats

Sefa Ince, Mehmet Ozer, Berrin Goktug Kadioglu, Mehmet Kuzucu, Betul Gundogdu, Cebrail Gursul, Zeynep Suleyman and Halis Suleyman Halis  Suleyman's LiveDNA
Background and Objective: Interleukin 1 beta (IL-1β) and tumour necrosis factor-alpha (TNF-α) as the proinflammatory cytokines, whose production increases during reperfusion after ischemia (I/R), were reported to produce the Reactive Oxygen Species (ROS). It was reported that sunitinib has proinflammatory cytokine expression suppression and antioxidant effects. The study aims to investigate the effects of sunitinib on ovarian injuries created by I/R in albino Wistar female rats biochemically and histopathologically. Materials and Methods: Animals divided into 3 groups as sunitinib+ovarian tissues (SOIR), I/R ovarian tissues (OIR) and Sham operation (SG) groups. There were ischemia and reperfusion procedures for 2 hrs on the right ovaries of the OIR and SOIR group rats. Results: The Nuclear Factor kappa B (NF-κB), Tumour Necrosis Factor-alpha (TNF-α), Malondialdehyde (MDA) and Interleukin 1 beta (IL-1β) levels in the OIR group’s ovarian tissue were high whereas their total glutathione (tGSH) level was found to be low compared to the SOIR and SG group. While distinct histopathologic injuries were seen in the ovarian tissue of the OIR group, histopathologic injuries in the SOIR group were mild. Conclusion: Sunitinib prevented the oxidant and proinflammatory cytokine increase and antioxidant decrease related to I/R. It is concluded that sunitinib might be used for the treatment of ovarian I/R injuries.
PDF Fulltext XML References Citation

How to cite this article

Sefa Ince, Mehmet Ozer, Berrin Goktug Kadioglu, Mehmet Kuzucu, Betul Gundogdu, Cebrail Gursul, Zeynep Suleyman and Halis Suleyman, 2021. Biochemical and Histopathological Evaluation of Sunitinib Effect on Ovarian Injuries by Ischemia-Reperfusion in Rats. International Journal of Pharmacology, 17: 65-72.

DOI: 10.3923/ijp.2021.65.72

URL: https://scialert.net/abstract/?doi=ijp.2021.65.72

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved